Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Danchin, N.
Right arrow Articles by Durand, E.
PubMed
Right arrow Articles by Danchin, N.
Right arrow Articles by Durand, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org

Optimizing outcomes in patients with STEMI: mortality, bleeding, door-to-balloon times, and guidelines: the approach to regional systems for STEMI care: defining the ideal approach to reperfusion therapy based on recent trials

Nicolas Danchin*, Rocio Carda, Aurès Chaib, Antoine Lepillier and Eric Durand

Department of Cardiology, Hôpital Européen Georges Pompidou, 20 rue Leblanc 75015, Paris, France

* Corresponding author. Tel: +33 156092571; fax: +33 156092572. E-mail address: nicolas.danchin{at}egp.aphp.fr

Achieving rapid reperfusion is an essential step in the management of ST-elevation myocardial infarction (STEMI). Although primary percutaneous coronary intervention (PCI) is the preferred option, alternative strategies, and in particular intravenous fibrinolysis, especially as part of a pharmaco-invasive approach (i.e. followed by rapid coronary angiography with PCI when necessary) offer a reasonable alternative, when practical considerations make the performance of timely primary PCI impossible. Concomitant antithrombotic treatment is essential to grant optimal clinical results. This includes both antiplatelet and anticoagulant medications, with the aim to improve efficacy, without notably increasing bleeding complications, which are strong predictors of poor immediate and long-term outcomes. From a practical standpoint, network organization is central for optimizing patient care at the acute stage of MI. This review describes current approaches used to optimize outcomes in STEMI patients and their results in different systems of care.

Key Words: Myocardial infarction • Reperfusion therapy • Antithrombotic treatment • Bleeding • Outcomes


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.